SPOTLIGHT: Arixtra gets positive review in Europe


The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended that GlaxoSmithKline's Arixtra be approved for the prevention of venous thromboembolism in patients undergoing abdominal surgery who are at risk of thromboembolic complications. Release

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.